N
Normann Willich
Researcher at University of Münster
Publications - 216
Citations - 6261
Normann Willich is an academic researcher from University of Münster. The author has contributed to research in topics: Radiation therapy & Carcinoma. The author has an hindex of 36, co-authored 216 publications receiving 5809 citations.
Papers
More filters
Journal ArticleDOI
Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92.
Peter Koch,Francisco del Valle,Wolfgang E. Berdel,Normann Willich,Berthold Reers,Wolfgang Hiddemann,Bernward Grothaus-Pinke,Gabriele Reinartz,Jens Brockmann,Altfried Temmesfeld,Rudolf Schmitz,C. Rübe,Andreas Probst,Gert Jaenke,Heinrich Bodenstein,Arved Junker,Christiane Pott,Jürgen Schultze,Achim Heinecke,R. Parwaresch,M. Tiemann +20 more
TL;DR: In this paper, a study was conducted to obtain anatomic and histologic distribution, clinical features, and treatment results in patients with primary gastrointestinal non-Hodgkin's lymphomas (PGI NHL).
Journal ArticleDOI
Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group
Andreas Engert,Petra Schiller,Andreas Josting,Richard Herrmann,Peter Koch,M. Sieber,F. Boissevain,Maike de Wit,Jörg Mezger,Eckhart Dühmke,Normann Willich,Rolf-Peter Müller,Bernhard F. Schmidt,Helmut Renner,Hans Konrad Müller-Hermelink,Beate Pfistner,Jürgen Wolf,Dirk Hasenclever,Markus W. Löffler,Volker Diehl +19 more
TL;DR: Radiotherapy volume size reduction from EF to IF after COPP + ABVD chemotherapy for two cycles produces similar results and less toxicity in patients with early-stage unfavorable HD.
Journal ArticleDOI
Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
Hans Theodor Eich,Volker Diehl,Helen Görgen,Thomas Pabst,Jana Markova,Jürgen Debus,Anthony D. Ho,Bernd Dörken,Andreas Rank,Anca-Ligia Grosu,Thomas Wiegel,Johann H. Karstens,Richard Greil,Normann Willich,Heinz Schmidberger,Hartmut Döhner,Peter Borchmann,Hans Konrad Müller-Hermelink,Rolf-Peter Müller,Andreas Engert +19 more
TL;DR: Moderate dose escalation using BEACOPP(baseline) did not significantly improve outcome in early unfavorable HL, and four cycles of ABVD should be followed by 30 Gy of IFRT.
Journal ArticleDOI
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial
Thomas Wiegel,Detlef Bartkowiak,Dirk Bottke,Claudia Bronner,Ursula Steiner,Alessandra Siegmann,Reinhard Golz,Stephan Störkel,Normann Willich,Axel Semjonow,Michael Stöckle,Christian Rübe,Udo Rebmann,T. Kälble,Horst Jürgen Feldmann,Manfred P. Wirth,Rainer Hofmann,Rita Engenhart-Cabillic,Axel Hinke,Wolfgang Hinkelbein,Kurt Miller +20 more
TL;DR: Compared with WS, ART reduced the risk of (biochemical) progression with a hazard ratio of 0.51 in pT3 PCa, and with only one grade 3 case of late toxicity, ART was safe.
Journal ArticleDOI
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Rolf D. Kortmann,Joachim Kühl,Beate Timmermann,Uwe Mittler,Christian Urban,Volker Budach,Eckart Richter,Normann Willich,Michael Flentje,Frank Berthold,Slavc I,Johannes Wolff,Christoph Meisner,Otmar D. Wiestler,Nils Sörensen,Monika Warmuth-Metz,Michael Bamberg +16 more
TL;DR: Maintenance chemotherapy would seem to be more effective in low-risk medulloblastoma, especially in patients older than 6 years of age, and quality control of radiotherapy revealed correct treatment in more than 88% for dose prescription, more than 90% for coverage of target volume, and 98% for field matching.